InterMune prices public offering of newly issued common stock

InterMune, Inc. (Nasdaq: ITMN) today announced the pricing of its underwritten public offering of 7,000,000 shares of newly issued common stock at a price to the public of $14.10 per share.

InterMune also granted the underwriters a 30-day option to purchase up to an additional 1,050,000 shares of its common stock.  All of the shares in the offering are being sold by InterMune. The shares will be issued pursuant to a prospectus supplement filed as part of a shelf registration statement previously filed with the Securities and Exchange Commission (SEC) on Form S-3.  InterMune anticipates aggregate net proceeds from the offering to be $92.8 million (assuming no exercise of the underwriters' option to purchase additional shares of common stock).  

Goldman, Sachs & Co. is acting as the sole book-running manager of the offering.  Canaccord Adams, JMP Securities LLC, Leerink Swann LLC, and Oppenheimer & Co. Inc. are acting as co-managers.  InterMune expects to close the offering on or about January 26, 2010, subject to customary closing conditions.  

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.